Volume 216 - Issue 8

Chemical analysis of fresh and aged Australian e‐cigarette liquids

Authors:  Alexander Larcombe, Sebastien Allard and Benjamin Mullins

Med J Aust 2022; 216 (8): 430-430. || doi: 10.5694/mja2.51481
Published online: 2 May 2022

In reply

In reply: We thank the Mendelsohn and Wodak1 for their interest and assessment of our study.2 We would like to respond with clarifying information.

We challenge the statement that “frequent vaping is largely confined to smokers”. While this may be true for older smokers, considerable evidence exists that vaping in non‐smokers and adolescents is rapidly increasing, that younger vapers are unlikely to use e‐cigarettes for smoking cessation,3 and that e‐cigarette use increases the risk of tobacco smoking.4 The argument that vaping is safer than smoking is moot for these users.

The authors state “the risk to human health depends on the level of exposure”. We agree and, therefore, we made no definitive statements as to whether the chemicals detected would have an impact on health. Many assumptions are required for such a statement, as there is no “typical” e‐cigarette user. It is obvious that multiple factors (device type/settings, puff volume/frequency, e‐liquid composition etc) affect the volume of chemicals inhaled. Hence our call for more research in this area.

We also agree (and state) that e‐cigarette aerosol analysis is important. It is likely that aerosols will contain a wider array of potentially toxic chemicals generated by thermal degradation of excipients and other ingredients.5 E‐liquid analysis provides valuable information in that chemicals identified are very likely to also be present in the aerosols.

The authors’ dismissal of the effect of flavouring chemicals is alarming, considering the mounting evidence of the toxicity of many flavourants.6 Dismissing other chemicals because they are at “low or very low levels” is also concerning given a lack of evidence for the health effects of heating and repeatedly inhaling many e‐liquid chemicals over long periods. Further, the Public Health England endorsement of e‐cigarette safety and efficacy has been widely questioned by many leading organisations, including the British Medical Association, the American Lung Association, and the World Health Organization.7

Mendelsohn and Wodak are disappointed that we did not state any competing interests. We openly declare the funders of the project and reiterate that there are no competing interests. The funders played no role in study design, execution, data analysis or interpretation.

 


Authors


Competing interests


Acknowledgements


References


Linked content

  • MJA Research: Chemical analysis of fresh and aged Australian e‐cigarette liquids

  • MJA Letter: Chemical analysis of fresh and aged Australian e‐cigarette liquids